What is the recommended staging workup and treatment strategy for esophageal squamous cell carcinoma?

Squamous Cell Carcinoma of the Oesophagus

Staging Workup

For esophageal squamous cell carcinoma, perform comprehensive staging with endoscopy, contrast-enhanced CT or FDG-PET/CT, and endoscopic ultrasound (EUS) to guide treatment decisions 1.

Essential Staging Components:

• Physical examination with particular attention to head and neck region to exclude second primary tumours (present in 6.7% of ESCC patients) 1

• Endoscopy for direct tumour visualization and biopsy

• CT chest/abdomen or FDG-PET/CT to identify distant metastases (PET/CT is particularly valuable before planned esophagectomy to avoid futile surgery) 1

• Endoscopic ultrasound (EUS) for T and N staging, especially useful for:

  • Assessing T4b status with invasion of airways, pericardium, or aorta
  • Identifying and biopsying lymph nodes outside standard radiation fields 1
  • Note: EUS has low accuracy for T1 tumours; endoscopic resection provides better staging in these cases 1

• Bronchoscopy with endobronchial ultrasonography when tumour stricture precludes EUS or when assessing airway involvement 1

Additional Risk Assessment:

• Differential blood count, liver/pulmonary/cardiac/renal function tests
• Nutritional status evaluation (>50% lose >5% body weight; 40% lose >10%) 1
• Physical fitness assessment (reduced activity predicts worse outcomes) 1

---

Treatment Strategy

For locally advanced esophageal squamous cell carcinoma, offer preoperative chemoradiotherapy followed by surgery, OR definitive chemoradiotherapy without immediate surgery 2.

Treatment Algorithm by Clinical Scenario:

Scenario 1: Surgically Fit Patient, Favorable Tumour Location

• Preoperative CRT → Surgery (preferred)
• Cisplatin/5-FU based chemoradiotherapy
• Surgery with adequate lymphadenectomy (goal: ≥16-18, preferably ≥20 lymph nodes) 2

Scenario 2: Complete Response to CRT

• Surveillance with salvage surgery option may be considered 2
• Historical data suggest minimal benefit from adding surgery after complete response
• Ongoing trials (pre-SANO, Esostrate-Prodige 32) are evaluating this approach 2

Scenario 3: Cervical Esophageal Location

• Definitive CRT (surgery reserved for persistent/recurrent disease) 2

Scenario 4: Patient Cannot Tolerate Surgery

• Definitive CRT without surgery 2
• Higher comorbidity burden
• Patient preference against surgery
• Tumour proximity to larynx

Scenario 5: Radiation Not Feasible

• Preoperative chemotherapy alone (without radiation) may be considered 2

---

Critical Treatment Considerations

Surgery vs. No Surgery Decision:

The decision to add surgery after CRT should incorporate shared decision-making considering age, comorbidities, patient preference, and caregiver support 2.

• Key evidence: Meta-analysis of two studies found no difference in overall survival but increased treatment-related mortality with preoperative CRT + surgery compared to CRT alone in squamous cell carcinoma 2
• However: Both preoperative CRT and definitive CRT show more pronounced benefit in squamous cell carcinoma compared to adenocarcinoma 2

Surgical Quality Matters:

Radiation benefit is greater with less extensive surgery. Adequate surgery requires 2:

• Clear surgical margins (R0 resection)
• Adequate nodal dissection in appropriate fields (abdominal and thoracic)
• Goal of ≥16-18, preferably ≥20 lymph nodes examined

Common Pitfalls to Avoid:

1. Don't skip PET/CT in surgical candidates—it identifies occult metastases in a significant proportion and prevents futile surgery 1
2. Don't miss head and neck second primaries—examine thoroughly as they worsen prognosis 1
3. Don't neglect nutritional support—weight loss increases operative risk and worsens quality of life regardless of BMI 1
4. Don't assume all patients need immediate surgery after CRT—complete responders may benefit from surveillance approach 2

---

Staging System

Use AJCC/UICC TNM 8th edition for anatomic staging 1.